Crispr therapeutics insider trading
WebInsider trades for Crispr Therapeutics AG (CRSP). Monitor SEC Form 4 Insider Trading Filings for Insider Buying and Selling. Real-time Insider Trading Stock Screener. Long … WebThe Short Squeeze Score is the result of a sophisticated, multi-factor quantitative model that identifies companies that have the highest risk of experiencing a short squeeze. The scoring model uses a combination of short interest, float, short borrow fee rates, and other metrics. The number ranges from 0 to 100, with higher numbers indicating ...
Crispr therapeutics insider trading
Did you know?
WebApr 1, 2024 · CRISPR Therapeutics AG (NASDAQ:CRSP - Get Rating) CEO Samarth Kulkarni sold 25,000 shares of the company's stock in a transaction dated Wednesday, March 29th. The stock was sold at an average price of $44.46, for a total value of $1,111,500.00. Following the transaction, the chief executive officer now directly owns …
Web16 hours ago · CRISPR Therapeutics AG (NASDAQ:CRSP) is something of a hot-button topic by virtue of its very existence.But one analyst, in particular, is less interested in the controversy than in the potential involved in this biotech stock.The resulting fresh coverage with a positive rating helped send CRISPR up over 16% in Thursday afternoon’s trading. WebApr 12, 2024 · Kistler Tiffany Companies LLC grew its holdings in CRISPR Therapeutics AG (NASDAQ:CRSP - Get Rating) by 439.3% during the fourth quarter, according to the company in its most recent filing with the Securities and Exchange Commission.The firm owned 4,217 shares of the company's stock after acquiring an additional 3,435 shares …
WebApr 3, 2024 · CRISPR Therapeutics and Vertex Complete Submission of Rolling Biologics License Applications (BLAs) to the US FDA for exa-cel for the Treatment of Sickle Cell … WebApr 4, 2024 · A short interest ratio ranging between 1 and 4 generally indicates strong positive sentiment about a stock and a lack of short sellers. A short interest ratio of 10 or greater indicates strong pessimism about a stock. CRSP shares currently have a short interest ratio of 10.0. Learn More on CRISPR Therapeutics's short interest ratio.
WebFind real-time CRSP - CRISPR Therapeutics AG stock quotes, company profile, news and forecasts from CNN Business.
Web1 day ago · CRISPR Therapeutics AG (CRSP) closed the last trading session at $45.41, gaining 0.6% over the past four weeks, but there could be plenty of upside left in the stock if short-term price targets ... ryan reynolds and i swearWebMar 29, 2024 · Learn More about insider trades at CRISPR Therapeutics. ... Samarth Kulkarni Insider Trading History at CRISPR Therapeutics. Transaction Date Buy/Sell … ryan reynolds and jack hughmanWeb10 rows · Apr 9, 2024 · How much insider selling is happening at CRISPR Therapeutics? Insiders have sold a total of ... ryan reynolds and hugh jackman commercialsWeb21 hours ago · Cantor Fitzgerald initiated coverage on CRISPR Therapeutics AG CRSP with an Overweight rating and a price target of $72, citing an interesting gene editing play … is ebay iphone goodWebMar 25, 2024 · Given the large stake in the stock by institutions, CRISPR Therapeutics' stock price might be vulnerable to their trading decisions 50% of the business is held by … is ebay money back guarantee goodWeb16 hours ago · CRISPR Therapeutics AG (NASDAQ:CRSP) is something of a hot-button topic by virtue of its very existence.But one analyst, in particular, is less interested in the … is ebay more ethical than amazonWebApr 13, 2024 · Shares of CRISPR Therapeutics stock opened at $43.47 on Thursday. CRISPR Therapeutics has a 52 week low of $38.94 and a 52 week high of $86.95. The stock has a 50 day moving average price of $47.74 and a two-hundred day moving average price of $50.87. The stock has a market capitalization of $3.42 billion, a PE ratio of -5.19 … ryan reynolds and hugh jackman friendship